Search Results 51-60 of 19089 for alzheimers
Lecanemab (Leqembi) is a medicine given to slow the progression of mild Alzheimer's disease (AD). This medicine reduces clumps of proteins called amyloid ...
The Alzheimer's Association convened the work group as new clinical data are expected soon from several studies of emerging therapeutics. Interpretation of ...
Providing care for someone who has Alzheimer's disease can be physically and emotionally hard. It often takes a great deal of patience, compassion and ...
Lewy body dementia, also known as LBD, is the second most common type of dementia after Alzheimer's disease. Protein deposits called Lewy bodies develop in ...
Alzheimer's disease is a progressive disease that destroys memory and other important mental functions. Many people who have relatives with this disease ...
Mayo Clinic has found that cognitive and behavioral changes can be detected nearly two decades before the onset of Alzheimer's symptoms. That time lag ...
It can often be mistaken for Alzheimer's disease. The good news: Limbic-predominant Amnestic Neurodegenerative Syndrome, or LANS, progresses more slowly and has ...
They're approved for people with mild Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease. Clinical trials found that the medicines ...
Wandering and becoming lost is common among people with Alzheimer's disease or other disorders causing dementia. This behavior can happen in the early ...
The Neuroimaging Core helps diagnose and track Alzheimer's disease and other dementias by providing important brain scan data for research projects and clinical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.